Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peroxiredoxin 2 pseudogene 3 (PRDX2P3) is classified as a pseudogene, which means it is a non-functional segment of DNA that arises from a previously functional gene but has accumulated mutations—such as frameshifts or premature stop codons—rendering it incapable of encoding a functional protein[4][6]. PRDX2P3 is related to the peroxiredoxin family, specifically peroxiredoxin 2 (PRDX2), which encodes an antioxidant enzyme that reduces hydrogen peroxide and alkyl hydroperoxides in cells[1]. However, PRDX2P3, as a pseudogene, does not produce any protein product and has no known biological activity or role in human disease. PRDX2P3 is a non-functional pseudogene derived from the peroxiredoxin 2 gene. It does not encode a functional protein or participate in any known biological pathway or disease process, nor does it interact with therapeutic agents. It should not be considered a therapeutic target, and its appearance in a drug target list is likely due to database noise or misannotation[4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peroxiredoxin 2 pseudogene 3 (PRDX2P3).